个人简介：Dr. Jianguo (James) Yang has over 20-year extensive experience in biopharma industry. Currently, Dr. Yang is President / CEO Abpro-China ( Abpro, a Biotech company based in Boston area, USA). Before joining Abpro, Dr. Yang was CSO / VP Biologics in Qilu Pharmaceuticals, and also had scientific leadership positions in several global 500 pharmaceutical companies, including in Abbott Lab Pharma Division (current AbbVie), MedImmune /AstraZeneca, Genzyme / Sanofi. Dr. Yang has published numerous patents and scientific papers, and is an editor advisor and reviewer for Bioprocess International (Journal), and Executive Director, Sino-America Pharmaceutical Association-NE (2012-2014), and reviewer for several scientific journals. As international recognized scientist in biopharma Industry, Dr. Yang is a frequently-invited speaker for international biotech/biopharma conferences. Dr. Yang got his Ph.D. in cell/molecular biology from Illinois Institute of Technology, USA.